Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
NCT: NCT04502316 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.
Frequently Asked Questions
What is Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)?
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry) is a clinical trial registered under NCT04502316. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04502316?
The current status of NCT04502316 (Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)) is: ACTIVE_NOT_RECRUITING.
When did Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry) start?
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry) started on 2020-06-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.